Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Charlottesville, Virginia Clinical Trials

A listing of Charlottesville, Virginia clinical trials actively recruiting patient volunteers.

RESULTS

Found (72) clinical trials

Advanced Immunoclinical Phenotyping of Rejection in Lung Transplant

Chronic allograft rejection of the transplanted lung (CLAD) is a major health issue that lead to almost 50% mortality within 5 years from the time of lung transplant. In the past CLAD was exclusively occurring in small airways causing a condition called "Bronchiolitis Obliteran Syndrome" (BOS). However, recently many have ...

Phase N/A

5.55 miles

Learn More »

Voice Outcomes Following Thyroidectomy

Voice difficulty is a common complaint following thyroidectomy, and while the procedure risks injury to laryngeal nerves involved in voice production, voice difficulty is common even in the absence of evident injury to these nerves. The cause of voice change in these situations is not well defined, and multiple mechanisms ...

Phase N/A

5.55 miles

Learn More »

A Study to Determine Frequency of DNA-repair Defects in Men With Metastatic Prostate Cancer

The purpose of this study is to evaluate the prevalence of 4 or more DNA-repair defects in a population of men with metastatic Prostate Cancer (PC) and to use the variants reported to assess biomarker eligibility for niraparib interventional studies.

Phase N/A

5.55 miles

Learn More »

Wearable Assessments in the Clinic and Home in PD

Subjects will be evaluated via both in-clinic and at-home assessments. The in-clinic assessments are designed to compare the ability of current Parkinson disease clinical trial measures with the ability of mobile and wearable devices to detect disease progression in the early stage of disease. The at-home assessments are designed to ...

Phase N/A

5.55 miles

Learn More »

PRECISION GRX Registry

This is a single-arm, open-label, multi-center patient registry of the CorPath GRX System to examine its performance during PCI procedures and patient outcomes through 72 hours post-procedure or hospital discharge, whichever occurs first.

Phase N/A

5.57 miles

Learn More »

Spinal Cord Injury Registry - NACTN

The participating centers include: University of Texas Health Science Center, Houston University of Toronto, Toronto University of Virginia, Charlottesville University of Louisville, Louisville University of Maryland, Baltimore Walter Reed National Military Medical Center, Bethesda, MD Thomas Jefferson University,Philadelphia University of Miami, Miami Brooke Army Medical Center, Fort Sam Houston; Louisiana ...

Phase N/A

5.57 miles

Learn More »

UVA Brain and Aortic Aneurysm Study

The investigators have previously generated estimates for cost effectiveness of each arm of this reciprocal screening protocol based on literature dervied estimates of coprevalence and other key factors in a decision tree model to compare costs and outcomes. They measured expected outcomes using quality-adjusted life years (QALY) and the incremental ...

Phase N/A

5.57 miles

Learn More »

OPsumit USers Registry

Prospective observational drug registry developed to characterize the safety profile (including primarily potential serious hepatic risks) and to describe clinical characteristics and outcomes of patients newly treated with Opsumit in the post-marketing setting.

Phase N/A

5.57 miles

Learn More »

Neurologic Complications in Spinal Deformity Surgery - Extension

Although the incidence of complications in patients undergoing correction of their spinal deformity has been reported extensively, the majority of these studies were retrospective. There were only five studies, three from a single institution, with prospectively collected data that specifically identified complications. The largest series was from Buchowski et al ...

Phase N/A

5.57 miles

Learn More »

Clinical Importance of Glucose Regulation in Relapsing MS

Multiple Sclerosis (MS) is a neuroinflammatory and degenerative central nervous system disorder. The majority of patients have an early relapsing-remitting course. Standard treatment for an MS-relapse is intravenous methylprednisolone (IVMP), typically 1000 mg daily for 3 days. Despite IVMP treatment, >40% of MS patients experience residual deficits after an MS-relapse. ...

Phase N/A

5.57 miles

Learn More »